Dr. Kevin Joseph Nesh, MD

Dr. Nesh practices at Holy Cross Hospital in Taos, New Mexico, part of Holy Cross Medical Center.

Dr. Nesh's NPI, 1407116858, was assigned on May 19, 2012. Dr. Nesh holds Florida license ME124726.

Dr. Nesh's primary practice is Holy Cross Hospital, at 1397 Weimer Road, Taos, NM 87571 in Taos County. The practice phone is (575) 758-8883.

Dr. Nesh's primary practice is Holy Cross Hospital in Taos, New Mexico, part of Holy Cross Medical Center. The medical group on file is Holy Cross Hospital. Dmand AI also links Dr. Nesh to 7 more medical groups, each named with a free account. Dr. Nesh's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nesh practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Nesh's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Nesh is licensed in Florida.

CMS data shows 107 Medicare services from Dr. Nesh across 4 procedure codes in 2024, for 68 Medicare patients. Medicare paid $9,330 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 68 Medicare patients who saw Dr. Nesh in 2024. The largest group is 65 to 74, with 22 patients. 69% of them have high blood pressure, and 59% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nesh's median patient age at 78, with 53% women.

In 2024, Dr. Nesh wrote 61 Medicare Part D claims for 34 patients. 89% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $53 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

Dr. Nesh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Nesh from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $62.